chr19:45910592:> Detail (hg19)
Information
Genome
| Assembly | Position |
|---|---|
| hg19 | chr19:45,910,592-45,982,086 |
| hg38 | chr19:45,407,334-45,478,828 |
HGVS
| Type | Transcript | Protein |
|---|---|---|
Summary
MGeND
| Clinical significance | |
| Variant entry | |
| GWAS entry | |
| Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
| Clinical Significance | |
| Review star | [No Data.] |
| Show details | |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
| Score | Disease name | Description | Source | Pubmed | Links |
|---|---|---|---|---|---|
| 0.005 | squamous cell carcinoma | ERCC1 mRNA levels were higher in tumors from patients with metastatic disease th... | BeFree,GAD | 24762590 | Detail |
| <0.001 | Carcinoma, Transitional Cell | ERCC1 as a Prognostic and Predictive Biomarker for Urothelial Carcinoma of the B... | BeFree | 26162296 | Detail |
| 0.001 | Malignant tumor of cervix | NA | BeFree | Detail | |
| 0.120 | Uterine Cervical Neoplasm | NA | BeFree,CTD_human | Detail | |
| 0.122 | Chromosome Aberrations | NA | CTD_human,GAD | Detail | |
| <0.001 | Congenital chromosomal disease | NA | BeFree | Detail | |
| 0.008 | Carcinoma of lung | Furthermore, a significant effect of SNPs in nucleotide excision repair pathway ... | BeFree | 21739480 | Detail |
| 0.067 | Malignant neoplasm of lung | Furthermore, a significant effect of SNPs in nucleotide excision repair pathway ... | BeFree | 21739480 | Detail |
| <0.001 | Cockayne syndrome | NA | BeFree | Detail | |
| <0.001 | Colonic Neoplasms | NA | BeFree | Detail | |
| 0.008 | Colorectal Neoplasms | The present study determines the specificity of a novel antibody, monoclonal ant... | BeFree,GAD,LHGDN | 24603753 | Detail |
| 0.002 | Deafness | NA | GAD | Detail | |
| 0.080 | Diabetes Mellitus, Experimental | NA | RGD | Detail | |
| 0.002 | Diabetes Mellitus, Non-Insulin-Dependent | NA | GAD | Detail | |
| <0.001 | diabetic retinopathy | NA | BeFree | Detail | |
| 0.002 | DNA Damage | NA | GAD | Detail | |
| <0.001 | Dwarfism | NA | BeFree | Detail | |
| 0.003 | Endometrial Neoplasms | NA | LHGDN | Detail | |
| <0.001 | Failure to Thrive | NA | BeFree | Detail | |
| <0.001 | Fanconi anemia | NA | BeFree | Detail | |
| 0.001 | glioblastoma | NA | BeFree | Detail | |
| 0.005 | Head and Neck Neoplasms | NA | GAD | Detail | |
| 0.002 | Hearing Loss, Partial | NA | GAD | Detail | |
| 0.002 | Heartburn | NA | GAD | Detail | |
| <0.001 | Hirschsprung Disease | NA | BeFree | Detail | |
| 0.003 | male infertility | NA | BeFree,GAD | Detail | |
| 0.012 | Glioma | In the single-locus analysis, six single-nucleotide polymorphisms [ERCC1 3' untr... | BeFree | 19124499 | Detail |
| <0.001 | Kidney Diseases | NA | BeFree | Detail | |
| 0.005 | Laryngeal neoplasm | NA | GAD | Detail | |
| 0.008 | leukemia | NA | BeFree,GAD | Detail | |
| 0.003 | osteosarcoma | We first report associations of four SNPs, ERCC1 Asn118Asn, ERCC1 Gln504Lys, ERC... | BeFree | 23098477 | Detail |
| <0.001 | Osteosarcoma of bone | We first report associations of four SNPs, ERCC1 Asn118Asn, ERCC1 Gln504Lys, ERC... | BeFree | 23098477 | Detail |
| 0.001 | chronic lymphocytic leukemia | NA | BeFree | Detail | |
| <0.001 | Leukemia, Lymphocytic, Acute, L1 | NA | BeFree | Detail | |
| 0.005 | Leukemia, Myelocytic, Acute | NA | BeFree,GAD | Detail | |
| 0.002 | myeloid leukemia | NA | GAD | Detail | |
| <0.001 | leukopenia | NA | BeFree | Detail | |
| 0.003 | Chronic Obstructive Airway Disease | NA | BeFree,GAD | Detail | |
| 0.109 | Lung Neoplasms | NA | GAD,LHGDN,RGD | Detail | |
| 0.002 | Lymphoma, Non-Hodgkin | NA | GAD | Detail | |
| 0.126 | melanoma | NA | BeFree,CTD_human,GAD | Detail | |
| <0.001 | Mesothelioma | Most analyzed polymorphisms in TS, MTHFR, and ERCC1 genes failed to predict outc... | BeFree | 25246386 | Detail |
| 0.002 | Mouth Neoplasms | NA | GAD | Detail | |
| 0.002 | multiple sclerosis | NA | GAD | Detail | |
| 0.002 | Myotonic dystrophy | NA | BeFree | Detail | |
| 0.005 | Nasopharyngeal Neoplasms | NA | GAD | Detail | |
| 0.002 | Neoplasm Recurrence, Local | NA | GAD | Detail | |
| 0.120 | Neoplasms, Germ Cell and Embryonal | NA | CTD_human | Detail | |
| 0.126 | Neoplasm Metastasis | Results showed that Trp/Trp genotype of XRCC1 Arg194Trp and AA genotype of ERCC1... | BeFree | 25690281 | Detail |
| 0.003 | neutropenia | NA | BeFree,GAD | Detail | |
| 0.002 | oligospermia | NA | GAD | Detail | |
| <0.001 | Degenerative polyarthritis | NA | BeFree | Detail | |
| 0.007 | ovarian carcinoma | Here, we show that Prostatic secretory protein 94 (PSP94) levels are reduced in ... | BeFree | 24186202 | Detail |
| 0.007 | ovarian carcinoma | Lentivirus-Mediated RNAi silencing targeting ERCC1 reverses cisplatin resistance... | BeFree | 25941922 | Detail |
| 0.003 | Pancreatic Neoplasm | NA | LHGDN | Detail | |
| 0.123 | Peripheral neuropathy | NA | BeFree,CTD_human,GAD | Detail | |
| 0.002 | Pharyngeal Neoplasms | NA | GAD | Detail | |
| <0.001 | Preleukemia | NA | BeFree | Detail | |
| <0.001 | progeria | NA | BeFree | Detail | |
| 0.005 | Prostatic Neoplasms | NA | LHGDN | Detail | |
| 0.003 | Rectal Neoplasms | NA | BeFree,GAD | Detail | |
| 0.080 | Reperfusion Injury | NA | RGD | Detail | |
| 0.134 | Stomach Neoplasms | NA | BeFree,CTD_human,GAD | Detail | |
| 0.123 | Testicular Neoplasms | NA | BeFree,CTD_human,LHGDN | Detail | |
| <0.001 | thalassemia | NA | BeFree | Detail | |
| <0.001 | neuropathy | Regarding paclitaxel toxicity: CYP2C8 HapC and CYP2C8 rs1934951 were associated ... | BeFree | 25495407 | Detail |
| <0.001 | anemia | Regarding paclitaxel toxicity: CYP2C8 HapC and CYP2C8 rs1934951 were associated ... | BeFree | 25495407 | Detail |
| <0.001 | Turner syndrome | NA | BeFree | Detail | |
| <0.001 | Werner syndrome | NA | BeFree | Detail | |
| 0.002 | xeroderma pigmentosum | NA | BeFree | Detail | |
| <0.001 | Ichthyosis, X-Linked | NA | BeFree | Detail | |
| <0.001 | B-Cell Lymphomas | The expression of a number drug resistance‑related proteins, including multidrug... | BeFree | 25269574 | Detail |
| 0.002 | diffuse large B-cell lymphoma | NA | GAD | Detail | |
| 0.002 | Small cell carcinoma of lung | The prognostic value of excision repair cross-complementation group 1 (ERCC1) in... | BeFree | 25375151 | Detail |
| 0.121 | Adenocarcinoma of lung (disorder) | NA | BeFree,CTD_human | Detail | |
| 0.002 | Malignant neoplasm of mouth | NA | GAD | Detail | |
| <0.001 | Malignant neoplasm of nasopharynx | NA | BeFree | Detail | |
| <0.001 | Malignant tumor of extrahepatic bile duct | ERCC1 mRNA expression as a postoperative prognostic marker in extrahepatic bile ... | BeFree | 24763983 | Detail |
| <0.001 | Malignant neoplasm of testis | NA | BeFree | Detail | |
| <0.001 | Agenesis of corpus callosum | NA | BeFree | Detail | |
| <0.001 | pancreatic carcinoma | NA | BeFree | Detail | |
| <0.001 | Carcinoma of extrahepatic bile duct | ERCC1 mRNA expression as a postoperative prognostic marker in extrahepatic bile ... | BeFree | 24763983 | Detail |
| <0.001 | Cancer of Nasopharynx | NA | BeFree | Detail | |
| <0.001 | Hereditary pancreatitis | NA | BeFree | Detail | |
| 0.121 | Nasopharyngeal carcinoma | ERCC1 Cys8092Ala and XRCC1 Arg399Gln polymorphisms predict progression-free surv... | BeFree | 25025378 | Detail |
| 0.067 | Malignant neoplasm of lung | Nucleotide excision repair gene ERCC1 19007T>C polymorphism contributes to lung ... | BeFree,GAD | 25051148 | Detail |
| <0.001 | Turcot syndrome (disorder) | NA | BeFree | Detail | |
| 0.002 | Xeroderma pigmentosum, group A | Because protein-protein interactions are essential for NER activity, we transfec... | BeFree | 25115435 | Detail |
| <0.001 | Xeroderma pigmentosum, group G | NA | BeFree | Detail | |
| <0.001 | 5,10-Methylenetetrahydrofolate reductase deficiency | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of colon stage IV | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of stomach stage IV | NA | BeFree | Detail | |
| <0.001 | Non-small cell lung cancer stage I | NA | BeFree | Detail | |
| <0.001 | gastric adenocarcinoma | NA | BeFree | Detail | |
| <0.001 | Nasopharyngeal cancer recurrent | NA | BeFree | Detail | |
| <0.001 | Non-small cell lung cancer metastatic | NA | BeFree | Detail | |
| 0.009 | Cancer of Head and Neck | NA | BeFree,GAD | Detail | |
| <0.001 | Squamous cell carcinoma of esophagus | NA | BeFree | Detail | |
| <0.001 | Adenocarcinoma Of Esophagus | NA | BeFree | Detail | |
| <0.001 | Transitional cell carcinoma of bladder | Further, ERCC1 mRNA expression and in vitro sensitivity to cisplatin were correl... | BeFree | 26162296 | Detail |
| 0.001 | stage, non-small cell lung cancer | NA | BeFree | Detail | |
| <0.001 | stage, ovarian epithelial cancer | NA | BeFree | Detail | |
| 0.001 | cervix carcinoma | NA | BeFree | Detail | |
| 0.120 | Arsenic Poisoning | NA | CTD_human | Detail | |
| <0.001 | pleomorphic carcinoma | Furthermore, the expression level of excision repair cross-complementation group... | BeFree | 26031756 | Detail |
| <0.001 | Adenocarcinoma, metastatic | ERCC1 mRNA levels were higher in metastatic adenocarcinoma NSCLC; TUBB3 mRNA lev... | BeFree | 24762590 | Detail |
| <0.001 | anaplastic astrocytoma | NA | BeFree | Detail | |
| <0.001 | malignant mesothelioma | NA | BeFree | Detail | |
| <0.001 | Infusion related reaction | Two SNPs associated with docetaxel toxicity were identified: CYP3A4*1B with infu... | BeFree | 25495407 | Detail |
| <0.001 | Malignant neoplasm of pancreas | NA | BeFree | Detail | |
| 0.006 | Malignant neoplasm of prostate | NA | BeFree,GAD | Detail | |
| 0.002 | Congenital Myotonic Dystrophy | NA | BeFree | Detail | |
| 0.003 | endometrial carcinoma | NA | BeFree,GAD | Detail | |
| <0.001 | Secondary malignant neoplasm of liver | NA | BeFree | Detail | |
| 0.002 | body mass | NA | GAD | Detail | |
| <0.001 | Malignant glioma | NA | BeFree | Detail | |
| <0.001 | Carcinoma of larynx | NA | BeFree | Detail | |
| 0.002 | Carcinogenesis | NA | BeFree | Detail | |
| 0.002 | prostate carcinoma | NA | BeFree | Detail | |
| 0.008 | Epithelial ovarian cancer | Lentivirus-Mediated RNAi silencing targeting ERCC1 reverses cisplatin resistance... | BeFree,GAD | 25941922 | Detail |
| 0.001 | Refractory cancer | NA | BeFree | Detail | |
| <0.001 | Stage III Colorectal Cancer | NA | BeFree | Detail | |
| 0.006 | breast carcinoma | The aim of this study was to examine the prognostic value of breast cancer susce... | BeFree | 25227663 | Detail |
| 0.008 | Carcinoma of lung | Nucleotide excision repair gene ERCC1 19007T>C polymorphism contributes to lung ... | BeFree | 25051148 | Detail |
| <0.001 | Malignant neoplasm of gastrointestinal tract | NA | BeFree | Detail | |
| <0.001 | Secondary malignant neoplasm of lymph node | Multivariate analysis found that an absence of lymph node metastases and high ER... | BeFree | 24763983 | Detail |
| <0.001 | colon carcinoma | NA | BeFree | Detail | |
| 0.002 | Carcinoma of bladder | NA | BeFree | Detail | |
| 0.003 | skin carcinoma | NA | BeFree,GAD | Detail | |
| <0.001 | Dissecting aneurysm of the thoracic aorta | NA | BeFree | Detail | |
| 0.120 | Cockayne Syndrome, Type II | NA | ORPHANET | Detail | |
| <0.001 | Testicular malignant germ cell tumor | NA | BeFree | Detail | |
| <0.001 | Growth failure | NA | BeFree | Detail | |
| 0.011 | ovarian neoplasm | NA | BeFree,LHGDN | Detail | |
| <0.001 | cancer recurrence | NA | BeFree | Detail | |
| <0.001 | Metastatic Prostate Carcinoma | NA | BeFree | Detail | |
| 0.002 | Colorectal cancer metastatic | NA | BeFree | Detail | |
| 0.020 | Malignant neoplasm of ovary | Here, we show that Prostatic secretory protein 94 (PSP94) levels are reduced in ... | BeFree,GAD | 24186202 | Detail |
| 0.020 | Malignant neoplasm of ovary | ERCC1 gene silencing effectively reversed SKOV3/DDP cell resistance to cisplatin... | BeFree,GAD | 25941922 | Detail |
| 0.002 | Gastrointestinal toxicity | NA | GAD | Detail | |
| 0.003 | Squamous cell carcinoma of the head and neck | Predictive Role of ERCC1 Expression in Head and Neck Squamous Cell Carcinoma Pat... | BeFree | 26066774 | Detail |
| <0.001 | sarcoma | NA | BeFree | Detail | |
| 0.002 | hearing impairment | NA | GAD | Detail | |
| <0.001 | Severe diarrhea | NA | BeFree | Detail | |
| 0.003 | Mammary Neoplasms | Using a one-step TaqMan-based qRT-PCR, 5 commonly used reference genes (ACTB, GA... | BeFree,GAD | 25445497 | Detail |
| <0.001 | Primary Peritoneal Carcinoma | NA | BeFree | Detail | |
| <0.001 | Xenograft Model | NA | BeFree | Detail | |
| <0.001 | Rectal Tumors | NA | BeFree | Detail | |
| 0.002 | Rash and Dermatitis Adverse Event Associated with Chemoradiation | Predictive Role of ERCC1 Expression in Head and Neck Squamous Cell Carcinoma Pat... | BeFree | 26066774 | Detail |
| 0.009 | stomach carcinoma | Polymorphic variants of base excision repair (APE1-D148E, XRCC1-R194W, XRCC1-R39... | BeFree | 20817763 | Detail |
| 0.156 | Non-small cell lung carcinoma | Our results indicate that SNPs in the NER genes ERCC1 (Asn118Asn, 15310G>C, 8... | BeFree | 16195237 | Detail |
| 0.120 | CAMFAK syndrome | NA | ORPHANET | Detail | |
| <0.001 | ALKALINE PHOSPHATASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 1 | NA | BeFree | Detail | |
| <0.001 | uterine corpus cancer | NA | BeFree | Detail | |
| 0.003 | Precursor Cell Lymphoblastic Leukemia Lymphoma | NA | LHGDN | Detail | |
| 0.080 | XFE progeroid syndrome | NA | MGD | Detail | |
| <0.001 | Urothelial Carcinoma | ERCC1 as a Prognostic and Predictive Biomarker for Urothelial Carcinoma of the B... | BeFree | 26162296 | Detail |
| <0.001 | liver carcinoma | NA | BeFree | Detail | |
| 0.010 | Malignant neoplasm of stomach | Polymorphic variants of base excision repair (APE1-D148E, XRCC1-R194W, XRCC1-R39... | BeFree | 20817763 | Detail |
| 0.120 | Pena Shokeir syndrome Type 2 | NA | ORPHANET | Detail | |
| <0.001 | Hirschsprung disease 1 | NA | BeFree | Detail | |
| <0.001 | Stage III Colorectal Cancer AJCC v7 | NA | BeFree | Detail | |
| 0.003 | myelodysplastic syndrome | NA | BeFree,LHGDN | Detail | |
| <0.001 | FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) | NA | BeFree | Detail | |
| <0.001 | Thymus Neoplasms | NA | BeFree | Detail | |
| <0.001 | Experimental Organism Basal Cell Carcinoma | NA | BeFree | Detail | |
| 0.002 | Hearing Loss | NA | GAD | Detail | |
| 0.017 | adenocarcinoma | ERCC1 mRNA levels were higher in tumors from patients with metastatic disease th... | BeFree,GAD,LHGDN | 24762590 | Detail |
| 0.017 | adenocarcinoma | Expression of TS gene was evidently higher in patients with adenocarcinoma than ... | BeFree,GAD,LHGDN | 25921119 | Detail |
| 0.080 | Alcoholic Intoxication, Chronic | NA | RGD | Detail | |
| <0.001 | ataxia telangiectasia | NA | BeFree | Detail | |
| 0.005 | azoospermia | NA | BeFree,GAD | Detail | |
| 0.002 | Biliary Tract Neoplasm | NA | GAD | Detail | |
| 0.019 | Malignant neoplasm of urinary bladder | NA | BeFree,GAD | Detail | |
| 0.003 | Bladder Neoplasm | NA | LHGDN | Detail | |
| 0.002 | Bone neoplasms | NA | GAD | Detail | |
| 0.003 | Brain Neoplasms | NA | BeFree,GAD | Detail | |
| 0.018 | Malignant neoplasm of breast | The aim of this study was to examine the prognostic value of breast cancer susce... | BeFree,GAD | 25227663 | Detail |
| <0.001 | Malignant tumor of colon | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of endometrium | NA | BeFree | Detail | |
| 0.003 | Malignant neoplasm of larynx | NA | BeFree,GAD | Detail | |
| <0.001 | Rectal Carcinoma | This is the first work to propose variants within the AREG and the ERCC1 genes a... | BeFree | 25026457 | Detail |
| <0.001 | Malignant neoplasm of skin | NA | BeFree | Detail | |
| 0.156 | Non-small cell lung carcinoma | ERCC1 mRNA levels were higher in metastatic adenocarcinoma NSCLC; TUBB3 mRNA lev... | BeFree,CTD_human,GAD | 24762590 | Detail |
| 0.156 | Non-small cell lung carcinoma | Genetic polymorphism of GSTP1 and ERCC1 correlated with response to platinum-bas... | BeFree,CTD_human,GAD | 24958519 | Detail |
| 0.156 | Non-small cell lung carcinoma | ERCC1 and the efficacy of cisplatin in patients with resected non-small cell lun... | BeFree,CTD_human,GAD | 25217323 | Detail |
| 0.156 | Non-small cell lung carcinoma | The aim of this study was to examine the prognostic value of breast cancer susce... | BeFree,CTD_human,GAD | 25227663 | Detail |
| 0.156 | Non-small cell lung carcinoma | Effect of ERCC1 polymorphism on the response to chemotherapy and clinical outcom... | BeFree,CTD_human,GAD | 25366790 | Detail |
| 0.156 | Non-small cell lung carcinoma | Excision repair cross complementation group 1 is a chemotherapy-tolerating gene ... | BeFree,CTD_human,GAD | 25434755 | Detail |
| 0.156 | Non-small cell lung carcinoma | ERCC1 mRNA expression is associated with the clinical outcome of non-small cell ... | BeFree,CTD_human,GAD | 25501233 | Detail |
| 0.156 | Non-small cell lung carcinoma | ERCC1 SNPs as Potential Predictive Biomarkers in Non-Small Cell Lung Cancer Pati... | BeFree,CTD_human,GAD | 25647444 | Detail |
| 0.156 | Non-small cell lung carcinoma | To explore the expression of TS, RRM, ERCC1, TUBB3 and STMN1 genes in the tissue... | BeFree,CTD_human,GAD | 25921119 | Detail |
| 0.156 | Non-small cell lung carcinoma | Furthermore, the expression level of excision repair cross-complementation group... | BeFree,CTD_human,GAD | 26031756 | Detail |
Annotation
Annotations
| Descrption | Source | Links |
|---|---|---|
| ERCC1 mRNA levels were higher in tumors from patients with metastatic disease than patients with non... | DisGeNET | Detail |
| ERCC1 as a Prognostic and Predictive Biomarker for Urothelial Carcinoma of the Bladder following Rad... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Furthermore, a significant effect of SNPs in nucleotide excision repair pathway on lung cancer survi... | DisGeNET | Detail |
| Furthermore, a significant effect of SNPs in nucleotide excision repair pathway on lung cancer survi... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The present study determines the specificity of a novel antibody, monoclonal antibody 4F9, and prese... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| In the single-locus analysis, six single-nucleotide polymorphisms [ERCC1 3' untranslated region (UTR... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| We first report associations of four SNPs, ERCC1 Asn118Asn, ERCC1 Gln504Lys, ERCC2 Asp312Asn and ERC... | DisGeNET | Detail |
| We first report associations of four SNPs, ERCC1 Asn118Asn, ERCC1 Gln504Lys, ERCC2 Asp312Asn and ERC... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Most analyzed polymorphisms in TS, MTHFR, and ERCC1 genes failed to predict outcome in mesothelioma ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Results showed that Trp/Trp genotype of XRCC1 Arg194Trp and AA genotype of ERCC1 rs2336219 have a si... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Here, we show that Prostatic secretory protein 94 (PSP94) levels are reduced in ovarian cancer patie... | DisGeNET | Detail |
| Lentivirus-Mediated RNAi silencing targeting ERCC1 reverses cisplatin resistance in cisplatin-resist... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Regarding paclitaxel toxicity: CYP2C8 HapC and CYP2C8 rs1934951 were associated with anemia; and ERC... | DisGeNET | Detail |
| Regarding paclitaxel toxicity: CYP2C8 HapC and CYP2C8 rs1934951 were associated with anemia; and ERC... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The expression of a number drug resistance‑related proteins, including multidrug resistance 1, multi... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The prognostic value of excision repair cross-complementation group 1 (ERCC1) in patients with small... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| ERCC1 mRNA expression as a postoperative prognostic marker in extrahepatic bile duct cancer. | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| ERCC1 mRNA expression as a postoperative prognostic marker in extrahepatic bile duct cancer. | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| ERCC1 Cys8092Ala and XRCC1 Arg399Gln polymorphisms predict progression-free survival after curative ... | DisGeNET | Detail |
| Nucleotide excision repair gene ERCC1 19007T>C polymorphism contributes to lung cancer susceptibilit... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Because protein-protein interactions are essential for NER activity, we transfected human cancer cel... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Further, ERCC1 mRNA expression and in vitro sensitivity to cisplatin were correlated in 25 bladder u... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Furthermore, the expression level of excision repair cross-complementation group 1 mRNA in PPC speci... | DisGeNET | Detail |
| ERCC1 mRNA levels were higher in metastatic adenocarcinoma NSCLC; TUBB3 mRNA levels were significant... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Two SNPs associated with docetaxel toxicity were identified: CYP3A4*1B with infusion-related reactio... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Lentivirus-Mediated RNAi silencing targeting ERCC1 reverses cisplatin resistance in cisplatin-resist... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The aim of this study was to examine the prognostic value of breast cancer susceptibility gene 1 (BR... | DisGeNET | Detail |
| Nucleotide excision repair gene ERCC1 19007T>C polymorphism contributes to lung cancer susceptibilit... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Multivariate analysis found that an absence of lymph node metastases and high ERCC1 expression were ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Here, we show that Prostatic secretory protein 94 (PSP94) levels are reduced in ovarian cancer patie... | DisGeNET | Detail |
| ERCC1 gene silencing effectively reversed SKOV3/DDP cell resistance to cisplatin and increased sensi... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Predictive Role of ERCC1 Expression in Head and Neck Squamous Cell Carcinoma Patients Treated with S... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Using a one-step TaqMan-based qRT-PCR, 5 commonly used reference genes (ACTB, GAPDH, RPLPO, GUSB, an... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Predictive Role of ERCC1 Expression in Head and Neck Squamous Cell Carcinoma Patients Treated with S... | DisGeNET | Detail |
| Polymorphic variants of base excision repair (APE1-D148E, XRCC1-R194W, XRCC1-R399Q and OGG1-S326C), ... | DisGeNET | Detail |
| Our results indicate that SNPs in the NER genes ERCC1 (Asn118Asn, 15310G>C, 8902G>T), XPA (-4G... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| ERCC1 as a Prognostic and Predictive Biomarker for Urothelial Carcinoma of the Bladder following Rad... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Polymorphic variants of base excision repair (APE1-D148E, XRCC1-R194W, XRCC1-R399Q and OGG1-S326C), ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| ERCC1 mRNA levels were higher in tumors from patients with metastatic disease than patients with non... | DisGeNET | Detail |
| Expression of TS gene was evidently higher in patients with adenocarcinoma than those with non-adeno... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The aim of this study was to examine the prognostic value of breast cancer susceptibility gene 1 (BR... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| This is the first work to propose variants within the AREG and the ERCC1 genes as promising predicti... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| ERCC1 mRNA levels were higher in metastatic adenocarcinoma NSCLC; TUBB3 mRNA levels were significant... | DisGeNET | Detail |
| Genetic polymorphism of GSTP1 and ERCC1 correlated with response to platinum-based chemotherapy in n... | DisGeNET | Detail |
| ERCC1 and the efficacy of cisplatin in patients with resected non-small cell lung cancer. | DisGeNET | Detail |
| The aim of this study was to examine the prognostic value of breast cancer susceptibility gene 1 (BR... | DisGeNET | Detail |
| Effect of ERCC1 polymorphism on the response to chemotherapy and clinical outcome of non-small cell ... | DisGeNET | Detail |
| Excision repair cross complementation group 1 is a chemotherapy-tolerating gene in cisplatin-based t... | DisGeNET | Detail |
| ERCC1 mRNA expression is associated with the clinical outcome of non-small cell lung cancer treated ... | DisGeNET | Detail |
| ERCC1 SNPs as Potential Predictive Biomarkers in Non-Small Cell Lung Cancer Patients Treated With Pl... | DisGeNET | Detail |
| To explore the expression of TS, RRM, ERCC1, TUBB3 and STMN1 genes in the tissues of patients with n... | DisGeNET | Detail |
| Furthermore, the expression level of excision repair cross-complementation group 1 mRNA in PPC speci... | DisGeNET | Detail |
Overlapped Transcript Coordinates
| Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
|---|
Overlapped Transcript
| Gene | Transcript ID | Chromosome | Start | Stop | Links |
|---|
- Gene
- -
- dbSNP
- rs386493716 dbSNP
- Genome
- hg19
- Position
- chr19:45,910,592-45,982,086
- Variant Type
- snv
Genome browser